This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.
Ultra-sharp, tri-beveled needle designed to minimize discomfort
Bethlehem, Pa. (PRWEB) February 01, 2013
The B. Braun OEM Division (http://www.bbraunoem.com) of B. Braun Medical Inc. – an FDA-registered, ISO 13485 provider of contract manufacturing services and components for medical devices and custom kits – now offers a broad line of competitively priced bulk, non-sterile hypodermic needles in a wide range of gauges and lengths.
The needles feature a smooth surface with a light silicone coating and an ultra-sharp, tri-beveled profile designed to promote ease of penetration and to minimize discomfort and pain.
The transparent Luer lock needle hubs are designed to promote visibility and facilitate flashback detection. They are color coded for easy identification.
Available as a stand-alone component or integrated into a custom kit, bulk hypodermic needles are the newest addition to the company’s existing portfolio of sterile and non-sterile syringes (available in two- and three- piece configurations) and sterile needles. They represent one of many kit components that B. Braun OEM Division offers including admixture devices, sets, valves, stopcocks, safety IV catheters and introducer needles, and interventional accessories.
For more information on hypodermic needles and syringes, contact the B. Braun OEM Division toll free at 866-8-BBRAUN or visit http://www.bbraunoem.com.
About B. Braun OEM Division
B. Braun OEM Division (http://www.bbraunoem.com) delivers complete contract manufacturing capabilities focusing on fluid administration and admixture products, kits, valves, catheters and interventional accessories. OEM takes customers’ designs from the earliest stages through design prototyping, assembly, packaging and sterilization. The B. Braun OEM Division of B. Braun Medical Inc. is based in Bethlehem, Pa.
About B. Braun
Since the early 19th Century, B. Braun has met a myriad of challenges in modern medical therapy with meaningful and trusted solutions. The B. Braun group of companies, including B. Braun, Aesculap® and Central Admixture Pharmacy Services, Inc. (CAPS®), represent thousands of innovations in acute pain management and infusion therapy that are intended to improve care and lower costs while reducing risks to patients and workers. Guided by the company’s “Sharing Expertise®” philosophy, B. Braun works with motivated partners and customers to address the critical issues of infection prevention, medication safety and environmental responsibility.
The B. Braun corporate mission to bring solutions that lead to better patient care have earned the company dozens of awards, certifications and recognitions for innovative products, employment practices, “green” initiatives and community responsibility throughout the world. Consistently recognized by Frost & Sullivan for its medical technology and support services, B. Braun provides professional training through its Aesculap Academy, reaching over 45,000 healthcare professionals each year, teaching best practices that help clinicians reduce medication errors, prevent healthcare-acquired infections (HAIs) and achieve sustainability objectives. For more information, call 800-227-2862, e-mail us at inquiry(dot)us(at)bbraun(dot)com or visit B. Braun at http://www.bbraunusa.com.
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2013/2/prweb10385419.htm